Align Technologyvs.Becton Dickinson
ALGN vs BDX · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Becton Dickinson is about 4.1× larger than Align Technology by market cap; Align Technology trades at the lower P/E (29.9 vs 53.2); year to date, Becton Dickinson leads (+25.0% vs +2.2%).
Side by side
| ALGN | BDX | |
|---|---|---|
| Market cap | $12.3B | $50.1B |
| Price | $159.61 | $189.78 |
| Today | −0.0% | −0.5% |
| Return YTD | +2.2% | +25.0% |
| Return 1Y | +6.7% | +21.5% |
| P/E | 29.9 | 53.2 |
| P/S | 3.0 | 2.4 |
| P/B | 2.9 | 2.1 |
Data as of 2026-08-26 · updates daily after U.S. close
The two companies
Align TechnologyALGN
Invisalign clear aligners, backed by digital dental scanning.
Full ALGN profile →Becton DickinsonBDX
Syringes and needles sit at the recognisable end of the range. Becton Dickinson's portfolio is broad, spanning medical consumables alongside diagnostic systems and drug delivery equipment.
Full BDX profile →More ALGN & BDX comparisons
Other head-to-heads in the Medtech & devices segment.
See where ALGN and BDX sit in the full Medicine, pharma & life science map: every segment from suppliers to end markets.Open the Life science value chain →